What's the deal with asthma and pro cycling?

Why do so many top-level cyclists suffer from asthma – and are the drugs that they're taking enhancing their performance?

Simon Yates at the 2015 Dauphine Libere; In April Yates tested positive for asthma medication (Watson)

(Image credit: Watson)

When it emerged in April that British pro Simon Yates had failed an in-competition test for the prohibited medication terbutaline, questions were asked about what the substance is and what effect it can have on riders and their performance.

According to his team, Yates is permitted to take the asthma medication under a Therapeutic Use Exemption (TUE), but an administrative error by a team doctor meant that this didn't apply on the day he was tested at Paris-Nice.

Thank you for reading 20 articles this month* Join now for unlimited access

Enjoy your first month for just £1 / $1 / €1

*Read 5 free articles per month without a subscription

Join now for unlimited access

Try first month for just £1 / $1 / €1

Founded in 1891, Cycling Weekly and its team of expert journalists brings cyclists in-depth reviews, extensive coverage of both professional and domestic racing, as well as fitness advice and 'brew a cuppa and put your feet up' features. Cycling Weekly serves its audience across a range of platforms, from good old-fashioned print to online journalism, and video.